“Electronic Nose” Accurately Sniffs Out Hard-to-Detect Cancers
Excerpt from the Article:
PHILADELPHIA—An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy, according to a new study from researchers at the University of Pennsylvania and Penn’s Perelman School of Medicine.
The findings suggest that the Penn-developed tool — which uses artificial intelligence and machine learning to decipher the mixture of volatile organic compounds (VOCs) emitting off cells in blood plasma samples — could serve as a non-invasive approach to screen for harder-to-detect cancers, such as pancreatic and ovarian.
The results will be presented at the annual American Society of Clinical Oncology meeting on June 4 by A. T. Charlie Johnson, PhD, the Rebecca W. Bushnell Professor of Physics and Astronomy in Penn’s School of Arts & Sciences (Abstract # 5544).
Click the button below to read the entire Article:
Discover What Sets TrialStat Apart From Ordinary Data Management
Click the image or button below to explore our interactive infographic which illustrates the comprehensive and unique capabilities of the TrialStat eClinical Suite.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?